The Future of Eye Care Is Here

Lumenis, the inventor of IPL, presents the first and only IPL FDA-approved for the management of dry eye disease.

Introducing OptiLIGHT – a bright solution for dry eyes. OptiLIGHT elevates dry eye management with Lumenis’ patented Optimal Pulse Technology (OPT™) and user-centered design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLIGHT, a dry eye medical device. 

​

How Does Intense Pulsed Light (IPL) therapy Help Dry Eye?

Intense pulsed light (IPL) therapy has become increasingly important to optometrists as a second-stage treatment for dry eye disease, particularly in improving meibomian gland dysfunction.

​

Intense pulsed light (IPL) therapy targets pigment and has been used in dermatology for over two decades to help remove skin lesions, such as telangiectasia, hemangiomas, and acne rosacea. More recently, the application of IPL has expanded within the ophthalmic space due to unexpected findings. It has been noted that dermatology patients who experience meibomian gland dysfunction (MGD) improved both symptoms and overall dry eye disease (DED) with IPL treatments.

​

​